CONMED (NASDAQ:CNMD) & Magna-Lab (NASDAQ:MAGAA) Financial Analysis

Share on StockTwits

Magna-Lab (OTCMKTS:MAGAA) and CONMED (NASDAQ:CNMD) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, analyst recommendations, earnings and risk.

Earnings & Valuation

This table compares Magna-Lab and CONMED’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Magna-Lab N/A N/A -$150,000.00 N/A N/A
CONMED $859.63 million 3.10 $40.85 million $2.18 43.17

CONMED has higher revenue and earnings than Magna-Lab.

Insider and Institutional Ownership

96.8% of CONMED shares are held by institutional investors. 15.3% of Magna-Lab shares are held by insiders. Comparatively, 4.4% of CONMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and target prices for Magna-Lab and CONMED, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Magna-Lab 0 0 0 0 N/A
CONMED 0 1 3 0 2.75

CONMED has a consensus price target of $94.75, suggesting a potential upside of 0.67%. Given CONMED’s higher possible upside, analysts clearly believe CONMED is more favorable than Magna-Lab.


CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 0.8%. Magna-Lab does not pay a dividend. CONMED pays out 36.7% of its earnings in the form of a dividend.


This table compares Magna-Lab and CONMED’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Magna-Lab N/A N/A -3,388.24%
CONMED 3.13% 9.95% 4.31%

Risk and Volatility

Magna-Lab has a beta of 8.67, suggesting that its share price is 767% more volatile than the S&P 500. Comparatively, CONMED has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500.


CONMED beats Magna-Lab on 9 of the 12 factors compared between the two stocks.

About Magna-Lab

Magna-Lab, Inc. is a shell company, which intends to identify and merge with an operating company. The company was founded by Lawrence A. Minkoff on February 22, 1991 and is headquartered in Syosset, NY.


CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and VCARE uterine manipulator for enhancing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

Receive News & Ratings for Magna-Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magna-Lab and related companies with's FREE daily email newsletter.